Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Sai Murali Krishna Pulukuri, Hugues Bernard et al.|Nature Chemical Biology|2017Cited by 228
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Scott Freeze et al.|Journal of Medicinal Chemistry|2021Cited by 205
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S. Lightcap, Dennis Huszar, Serge Y. Fuchs et al.|Science Translational Medicine|2021Cited by 139